Table 28:
Total Number of Patients with Diabetic Foot Ulcers Receiving HBOT per Year for Base Case and Scenario Analyses
| Variable | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Base case assuming no increase in capacity | 200 | 200 | 200 | 200 | 200 |
| Scenario analysis 1 assuming an increase in capacity (incidence rate from Hopkins et al51) | 465a | 731 | 996 | 1,261 | 1,527 |
| Scenario analysis 2 assuming increase in capacity (incidence rate from PHAC74) | 458 | 716 | 974 | 1,232 | 1,489 |
| Scenario analysis 3 assuming increase in capacity (incidence rate from ICES [Booth et al75], upper value) | 547 | 895 | 1,242 | 1,589 | 1,936 |
| Scenario analysis 4 assuming increase in capacity (incidence rate from ICES [Booth et al75], lower value) | 766 | 1,331 | 1,897 | 2,463 | 3,029 |
Abbreviations: HBOT, hyperbaric oxygen therapy; PHAC, Public Health Agency of Canada.
a
Sample calculation: (1,527 [estimated total number of patients with diabetic foot ulcers eligible for HBOT] – 200 [current number of patients treated]) ÷ 5 [years] + 200 [number of patients treated last year] = 465.